Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL7034152 | 0.88 | ALDH1A1 (0.38) | ALDH1A1DNM1LMNATSHR | |
| SCHEMBL3631072 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL25407559 | 0.83 | CA12 (0.36) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL7035333 | 0.81 | — | — | |
| SCHEMBL17367641 | 0.80 | — | — | |
| SCHEMBL13864172 | 0.77 | CA12 (0.35) | ALDH1A1LMNA | |
| SCHEMBL17367643 | 0.77 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL1713038 | 0.75 | CA12 (0.41) | ALDH1A1 | |
| Bromide SCHEMBL6155069 | 0.73 | CA12 (0.40) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL1535756 | 0.73 | CA12 (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150380168-A1 | THIN-LAYER CAPACITORS WITH LARGE SCALE INTEGRATION | SIEMENS AKTIENGESELLSCHAFT (DE) | 2015-12-31 | — | — | US | disclosed |
| US-7439395-B2 | Process for the preparation of guanidinium salts | MERCK PATENT GMBH (DE) | 2008-10-21 | — | — | US | disclosed |
| US-20070135645-A1 | Process for the preparation of guanidinium salts | MERCK PATENT GMBH (DE) | 2007-06-14 | — | — | US | disclosed |
| EP-1711458-A1 | METHOD FOR PRODUCING GUANIDINIUM SALTS | MERCK PATENT GmbH (DE) | 2006-10-18 | — | — | EP | disclosed |
| WO-2005075413-A1 | METHOD FOR PRODUCING GUANIDINIUM SALTS | MERCK PATENT GMBH (DE) | 2005-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135645-A1 | Process for the preparation of guanidinium salts | GMPS, AGPS, PFAS | ALDH1A1 2510/4885DNM1 2157/4885LMNA 2402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.